<VariationArchive RecordType="classified" VariationID="3873" VariationName="NG_009770.3:g.48585_63669del" VariationType="Deletion" Accession="VCV000003873" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-11-25" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="18912" VariationID="3873">
      <GeneList>
        <Gene Symbol="HEXB" FullName="hexosaminidase subunit beta" GeneID="3074" HGNC_ID="HGNC:4879" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>5q13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="74640023" stop="74721288" display_start="74640023" display_stop="74721288" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="73980968" stop="74017112" display_start="73980968" display_stop="74017112" Strand="+" />
          </Location>
          <OMIM>606873</OMIM>
        </Gene>
      </GeneList>
      <Name>NG_009770.3:g.48585_63669del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q13</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>16-KB DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009770.3" sequenceAccession="NG_009770" sequenceVersion="3" change="g.48585_63669del">
            <Expression>NG_009770.3:g.48585_63669del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="nssv1415027" DB="dbVar" />
        <XRef ID="nsv513799" DB="dbVar" />
        <XRef Type="Allelic variant" ID="606873.0001" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS expression for OMIM allelic variant 606873.0001 from the sequence across the breakpoint in Figure 5 of the paper by Neote et al., 1990 (PubMed 2147027).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NG_009770.3:g.48585_63669del AND Sandhoff disease" Accession="RCV000004077" Version="2">
        <ClassifiedConditionList TraitSetID="1058">
          <ClassifiedCondition DB="MedGen" ID="C0036161">Sandhoff disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1992-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1992-11-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <CitationText>Mahuran, D. J. Personal Communication. 1994. Toronto, Ontario, Canada</CitationText>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1386607</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1487253</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1975561</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2147027</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2921040</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1058" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4366" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GM2-GANGLIOSIDOSIS, TYPE II</ElementValue>
                <XRef Type="MIM" ID="268800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HEXOSAMINIDASES A AND B DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="268800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Beta-hexosaminidase-beta-subunit deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GM2 gangliosidosis, type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Total hexosaminidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hexosaminidase A and B deficiency Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sandhoff-Jatzkewitz-Pilz disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Sandhoff disease</ElementValue>
                <XRef ID="Sandhoff+disease/6408" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010006" DB="MONDO" />
                <XRef ID="23849003" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2521" />
                <XRef ID="2521" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Sandhoff disease comprises a phenotypic continuum encompassing acute infantile, subacute juvenile, and late-onset disease. Although classification into these phenotypes is somewhat arbitrary, it is helpful in understanding the variation observed in the timing of disease onset, presenting manifestations, rate of progression, and life span. Acute infantile Sandhoff disease (onset age &lt;6 months). Infants are generally normal at birth followed by progressive weakness and slowing of developmental progress, then developmental regression and severe neurologic impairment. Seizures are common. Death usually occurs between ages two and three years. Subacute juvenile Sandhoff disease (onset age 2-5 years). After attaining normal developmental milestones, developmental progress slows, followed by developmental regression and neurologic impairment (abnormal gait, dysarthria, and cognitive decline). Death (usually from aspiration) typically occurs in the early to late teens. Late-onset Sandhoff disease (onset older teen years or young adulthood). Nearly normal psychomotor development is followed by a range of neurologic findings (e.g., weakness, spasticity, dysarthria, and deficits in cerebellar function) and psychiatric findings (e.g., deficits in executive function and memory). Life expectancy is not necessarily decreased.</Attribute>
                <XRef ID="NBK579484" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">35420740</ID>
                <ID Source="BookShelf">NBK579484</ID>
              </Citation>
              <XRef ID="796" DB="Orphanet" />
              <XRef ID="C0036161" DB="MedGen" />
              <XRef ID="MONDO:0010006" DB="MONDO" />
              <XRef Type="MIM" ID="268800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="24243" SubmissionDate="2009-11-04" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606873.0001_SANDHOFF DISEASE" title="HEXB, 16-KB DEL_SANDHOFF DISEASE" />
        <ClinVarAccession Accession="SCV000024243" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1992-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">By field inversion gel electrophoresis (FIGE) of SfiI-digested chromosomal DNA, Bikker et al. (1989) demonstrated a 16-kb deletion in 1 allele of the HEXB gene in 2 apparently unrelated patients with Sandhoff disease (268800). Mahuran (1994) pointed out that the 50-kb deletion (50-KB DEL) originally reported by Bikker et al. (1989) is the same as the 16-kb deletion described by Neote et al. (1990). The size was incorrectly estimated by Bikker et al. (1989); see Bolhuis and Bikker (1992). In conventional Southern blot analysis, this deletion was masked by hybridization of bands from the other allele. Among 14 patients with Sandhoff disease from different parts of Europe, Bikker et al. (1990) found homozygosity for the deletion in 2 and heterozygosity in 7. It appeared that the deletion started in intron 5, extending in the 5-prime direction and causing the loss of exons 1 to 5 and the promoter area of the HEXB gene.</Attribute>
              <Citation>
                <ID Source="PubMed">2921040</ID>
              </Citation>
              <Citation>
                <CitationText>Mahuran, D. J. Personal Communication. 1994. Toronto, Ontario, Canada</CitationText>
              </Citation>
              <Citation>
                <ID Source="PubMed">2147027</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">1487253</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">1975561</ID>
              </Citation>
              <XRef DB="OMIM" ID="268800" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In DNA from fibroblasts of a patient with the infantile form of Sandhoff disease, Neote et al. (1990) identified a deletion of approximately 16 kb, including the HEXB promoter, exons 1 through 5, and part of intron 5. The deletion probably arose from recombination between 2 Alu sequences, with the breakpoints occurring at the midpoint between the left and right arms in each case and regenerating an intact Alu element in the deletion sequence. The deletion allele accounted for 8 of 30 Sandhoff mutant alleles analyzed. It was present in homozygous state in 2 cell lines from patients with the infantile form, in heterozygous form together with an intron 12 deletion in a juvenile case, and in heterozygous form in 2 adult Sandhoff cases. The last 3 cases plus 1 infantile case had the Alu-type deletion in compound heterozygous (i.e., heteroallelic) state (see 606873.0014). McInnes et al. (1992) reported that this 16-kb deletion accounted for 27% of the Sandhoff alleles they analyzed. This null allele was associated with the juvenile pro417-to-leu mutation (606873.0007) which interfered with the normal acceptor splice site. This combination in a French Canadian family was accompanied by a very mild phenotype which McInnes et al. (1992) attributed to differences in racial background.</Attribute>
              <Citation>
                <ID Source="PubMed">2147027</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">1386607</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXB" />
          </GeneList>
          <Name>HEXB, 16-KB DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">16-KB DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606873.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SANDHOFF DISEASE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="24243" TraitType="Disease" MappingType="Name" MappingValue="SANDHOFF DISEASE" MappingRef="Preferred">
        <MedGen CUI="C0036161" Name="Sandhoff disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>